Day: May 13, 2021

First Patient Dosed in Validive® Phase 2b/3 VOICE Clinical TrialCamsirubicin Run-in Clinical Trial Now Planned to Start in 2H 2021Potential Utility Reported for MNPR-101 as Imaging Agent in Cancer Surgery WILMETTE, Ill., May 13, 2021 (GLOBE NEWSWIRE) — Monopar Therapeutics Inc. (Monopar or the Company) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company primarily focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients, today announced first quarter 2021 financial results and recent business updates. Recent Business Updates ValidiveMonopar’s Phase 2b/3 VOICE clinical trial of Validive (clonidine HCl mucobuccal tablet) for the prevention of severe oral mucositis (SOM) in patients undergoing chemoradiotherapy (CRT) for oropharyngeal cancer (OPC) dosed its...

VANCOUVER, British Columbia, May 13, 2021 (GLOBE NEWSWIRE) — K92 Mining Inc. (“K92” or the “Company”) (TSX: KNT; OTCQX: KNTNF) is pleased to announce results from its financial statements for the three months ended March 31, 2021. SafetyStrong focus on safety with one of the best safety records in the Australasia region since start of operations. Proactive and focused management of COVID-19. K92 continues to operate and has strong preventative and response plans.ProductionRecord quarterly tonnage of 73,221 tonnes treated, a 54% increase from Q1 2020. Quarterly gold equivalent (“AuEq”) production of 18,654 oz, or 17,774 oz gold, 426,153 lbs copper and 7,925 oz silver. Cash costs of US$745/oz gold and all-in sustaining costs (“AISC”) of US$1,038/oz gold ounce(2). Long hole stoping continuing to perform well and to design on...

MANCHESTER, N.H., May 13, 2021 (GLOBE NEWSWIRE) — Allegro MicroSystems, Inc. (“Allegro”) (NASDAQ: ALGM), a global leader in sensing and power semiconductor technology, announced today President & Chief Executive Officer, Ravi Vig, and Chief Financial Officer, Paul Walsh, will be presenting virtually at the following upcoming investor conferences. 3rd Annual Mizuho Auto Technology Seminar 2021Date: May 19, 2021Presentation Time: 3:30 PM ET The Cowen 49th Annual Technology, Media & Telecom ConferenceDate: June 3, 2021Presentation Time: 4:30 PM ET The webcast information for these conferences can be accessed through the Investor Relations section of Allegro’s website (https://investors.allegromicro.com). Archived replays of each presentation will be available on the website after each event. About Allegro MicroSystems Allegro...

PARAMUS, N.J., May 13, 2021 (GLOBE NEWSWIRE) — ALEXANDER’S, INC. (New York Stock Exchange: ALX) announced today that it received notice from IKEA Property, Inc. of its election to exercise its purchase option of the Paramus, New Jersey property. The Company anticipates closing the sale in the fourth quarter of 2021. The purchase price is $75 million and after repayment of the $68 million mortgage, the Company expects to receive net cash proceeds of approximately $6 million after costs. The financial statement gain will be approximately $60 million and the tax gain will be approximately $63 million. The Company does not expect to pay a special dividend related to this transaction. Alexander’s, Inc. is a real estate investment trust that has seven properties in the greater New York City metropolitan area. CONTACT:MATTHEW IOCCO(201)...

Columbus, OH, May 13, 2021 (GLOBE NEWSWIRE) — Mettler-Toledo International Inc. (NYSE:MTD) today announced the webcast of its presentation at the 2021 UBS Global Healthcare Virtual Conference on Wednesday, May 26, 2021, at 12:00 p.m Eastern Time.  To hear a live webcast of the presentation, visit the investor relations page on the Company’s Web site at www.mt.com/investors.  A replay of the webcast will be available for seven days. METTLER TOLEDO (NYSE: MTD) is a leading global supplier of precision instruments and services. We have strong leadership positions in all of our businesses and believe we hold global number-one market positions in most of them. We are recognized as an innovation leader and our solutions are critical in key R&D, quality control, and manufacturing processes for customers in a wide range of industries...

SAN DIEGO, May 13, 2021 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing long-acting therapeutics designed to transform the standard of care for patients facing serious fungal or viral infections, today reported financial results for the three months ended March 31, 2021 and provided an update on its corporate activities and product pipeline. “We were pleased to recently announce our worldwide license and collaboration agreement with Janssen for the development and commercialization of our Cloudbreak® influenza AVCs,” said Jeffrey Stein, Ph.D., president and chief executive officer of Cidara. “The Janssen collaboration and our previously announced collaboration with Mundipharma for the development and commercialization of rezafungin, our novel, once-weekly echinocandin, validate our...

Received $1.0 Million Milestone Payment and Recognized $5.7 Million of License Revenue Under Exclusive License Agreement with 3D Medicines for Development and Commercialization of Galinpepimut-S (GPS) in Greater China National Ethics Committee Approval for GPS Phase 3 REGAL Study Received in Greece Preparations Underway to Activate Clinical Trial Sites and Enroll Patients in the REGAL Study in France, Germany and Greece by End of Second Quarter 2021 NEW YORK, May 13, 2021 (GLOBE NEWSWIRE) — SELLAS Life Sciences Group, Inc. (Nasdaq: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on developing novel cancer immunotherapies for a broad range of indications, today reported its financial results for the quarter ended March 31, 2021 and provided a business update. “Under our exclusive...

HOUSTON, Texas, May 13, 2021 (GLOBE NEWSWIRE) — Carriage Services, Inc. (NYSE: CSV) (“Carriage Services” or the “Company”) today announced that it closed its private offering of $400 million aggregate principal amount of 4.25% senior notes due 2029 (the “2029 Notes”). The Company used the net proceeds from the sale of the 2029 Notes, together with cash on hand and borrowings under the amended and restated credit facility, to satisfy and discharge the indenture with respect to its 6.625% senior notes due 2026 (the “2026 Notes”). The 2026 Notes are scheduled to be redeemed on June 1, 2021. This press release does not constitute a notice of redemption with respect to the 2026 Notes. The 2029 Notes are unsecured, senior obligations of the Company, and interest is payable semi-annually in arrears. The 2029 Notes are fully and unconditionally...